As the allergy season is starting, we at TIEFENBACHER PHARMACEUTICALS are thrilled to announce that we have successfully prepared the launch of the antihistamine Bilastine for a market entry as Over-the-counter (OTC) medicine in Germany.
Bilastine is an innovative anti-allergy medicine for patients suffering from allergic symptoms, such as hay fever and urticaria. It belongs to the non-sedating second-generation antihistamines. The 20 mg tablets have been developed in TIEFENBACHER GROUP´s own laboratories and will be marketed by our partner, a well-known international pharmaceutical company.
With this market entry we enable patients in Germany a better access to an important medicine which is currently the only product of this type available in pharmacies without a prescription needed. Further launches in European markets are planned soon.
For further information about our pharmaceuticals or medical devices please contact TIEFENBACHER PHARMACEUTICALS: info@aet.eu
TIEFENBACHER PHARMACEUTICALS is as a part of TIEFENBACHER GROUP – pioneering healthcare since 1963. Please visit us on: www.aet.eu and www.tiefenbachergroup.com
